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Keratin 9 mutation was examined in a Japanese kin-
dred of epidermolytic palmoplantar keratoderma 
(EPPK), which is a dominantly inherited autosomal 
disorder of keratinization characterized by diffuse 
thickening of the palms and soles and by epidermo-
lytic hyperkeratosis histologically. We report herein 
a novel mutation, a C ~ G transversion at nucleotide 
position 541 that converts a leucine residue (CTC) to 
E pidermolytic palmoplantar keratoderma (EPPK) is a dominantly inherited autosomal disorder of keratiniza-tion characterized by difli1se thickening of the palms and soles and by epidermolytic hyperkeratosis histolog-ically. For assembly of keratin intermediate filaments 
(KIF) , type I keratins fonn two-chain molecules w ith type II 
keratins, and the two-chain molecules then align correctly each 
other (Steinert, 1990). Since keratin 9 (K9) belongs to the type I 
keratin, which is expressed exclusively in palms and soles, muta-
tions of K9 have been examined in fami lies suffering fi·om tlus 
disease and were found in about half of the families (Bowden et nl, 
1994; 1-Iennies et nl, 1994; Reis et nl, 1994; Torchard el nl, 1994; 
Navsaria et nl, 1995; Rotlmagel et nl, 1995; Kobayashi et nl, 
1996). ' ·2 All these mutations ofK9 lie witlun the coil 1A region of 
the rod domain, which is considered to play a role in the conect 
alignment of the coiled-coil molecules (Steinert et nl, 1994). This 
was confirmed by an experiment that showed expression of a 
point-mutated K9 eDNA containing a G --'> A transition at nucl e-
otide position 551 has a dominant negative effect on the assembly of 
KIF in cells (Kobayaslu et n/, 1996). We report herein a novel 
mutation of a lughly conserved hydrophobic residu e in the lA 
domain of K9 in kindred of EPPK. 
MATER.IALS AND M ETHODS 
An EPPK family was analyzed, whose pedigree is described in Fig 1. All 
affected family members (L10 and 11.1) presented diffuse yellowish hyper-
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a valine (GTC) at codon 159. As in all other reported 
cases of keratin 9 mutation in EPPK, this mutation 
lies within the highly conserved coil 1A of the rod 
domain, which is considered to play a role in the 
correct alignment of the coiled-coil molecules. Key 
words: keratitt itttemtediate filament/helix iuitiatiott motif. 
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keratosis limited strictly to the pahm and soles. Patient 11.1 presented the 
symptom during tl1e first 6 mo after birth. On histologic ex;unination , they 
showed typical features of epidermolytic hyperkeratosis, including many 
large keratohyalin granules and pronounced vacuolization of the cells in the 
upper stratum spinosum. No unaffected fami ly members showed hyperker-
atosis of the palms or soles. 
Blood samples were obtained from 50 Japanese individuals who were nor 
suffering from any congenital disorders and were processed for preparation 
of genomic DNAs. Genomic DNAs were obtained from the periphera l 
white blood cell s as described previously (Poncz et nl , 1982). To detect K9 
mutations, highly conserved residues in the coillA ofK9 were amplified by 
the polymerase chain reaction (PCR). Primer sequences are 5' -GGTAT-
TCTGACTGCTAATGAG-3' (sense) and 5'-CTTCTGGATAGCAG-
CAGGTCC-3' (an ti- sense). Approximately 0.3 J.l.g of genomic DNA was 
amplified in each 100-f.l.l PCR. mixture consisting of 10 mM Tris(hy-
dro,.:ymethyl)aminomethane hydrochloride (pH 8.3), 50 mM KCl, 1.5 mM 
MgC12 , all four dcm.:ynucleotide triphosphate (each at 200 mM) , each 
primer at 1 J.l.M , and 5.0 units of Taq polym erase (Perkin-Elmer, Urayasu , 
Japan). PCR conditions were initial denaturation at 94°C for 2 min; 30 
cycles of 94°C for l min , 55 °C for 2 min, and 72°C for 3 min: and final 
extention at 72°C fo r 7 min. PCR products were subj ected directly to 
automated nucleotide sequencing (Applied Biosystems, Foster City. CA) . 
The mutation was confn·med by the mismatch PCR metl10d and allele-
specifi c oligonucleotide (ASO) hybridization. For the mismatch PCR, tl1e 
following probes were used: 5'-TGGAGGAGGCTATAGTAGTTC-3 ' 
(sense) and 5' -AAGAGGCCAGCCGAGAGTTGA-3 ' (anti-sense). PCR 
conditions were the same as above except for tl1 e annealing temperature, 
which was 48°C instead of 55°C. PCR products were digested by Hiucll, 
II 
2 
Figure 1. Pedigree of the family with EPPK. Solid symbols , affected 
individuals; o pen symbols, unaffected; •. 0, male; e, 0 . female. 
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3 ' -AACTCAAGG-5' 3'-AACT~GG-5' b 
5'-TTGAGTTCC-3' 5 ' -TTGAgTTCC-3' 
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Figure 2. Identification and verification of the missense mutation L159V in one K9 allele in affected individuals. (n) Automated sequencing 
reveals a C ~ G transversion at nucleotide position 541, which converts a leucine residue (CTC) to a valine (GTC). The upper and the lower sequences 
arc sense and anti-sense sequences , respectively. (/1) ASO showed that signals for the wi ld-type and the mutant sequences are present in the PCR. products 
of patients 1.10 and 11. 1, but only the wild-type signal is present in the unaffected family member Il.2 and the control sample. (c) For the mismatch PCR. 
method, PCR was performed with a modified primer that creates a Hiucll recognition site only if codon 159 contains the mutant. Mter digestion of the PCR 
products with Hiucll, the fragments were ana lyzed on a 5% polyacrylamide gel. The fragments of 178 bp and 197 bp represent the digested PCR products 
from the mutant all ele and the PCR products from the wild-type allele, respectively. Consequently, two fragments of 197 and 178 bp were observed in tl1e 
PCR products of afl"ectcd family members (1.10 and ll.l) , whereas the 197-bp fragment alone was observed in the PCR. products of unaffected family 
members (1.2, 1.5, 1.8, and 11 .2). 
and tbe digestion products were electrophoresed on 5% polyacrylamide gel. 
The fragments of 178 bp and 197 bp represent the digested PC.R products 
from tl1c mutant allele and the PCR products from the wild-type allele, 
respec tively. The ASO hybridization was performed as described elsewhere 
(Dietz ct nl, 1992) , and the probes were used as follows: wild type, 
5'-ATGCAGGAACTCAATTCTC-3'; mutant type, 5' -ATGCAG-
GAAGTCAA TTCTC-3 '. The numbering of base pairs and amino acids is 
accordiJJg to Langbein ct nl (1994). 
RESULTS 
The pedigree of the family with EPPK analyzed in tlus study is 
described in Fig 1. To detect K9 mutations, we amplified highly 
conserved residues in coil 1A of K9 by PCR. Direct nucleotide 
sequencing of the PCR products in all affected family members 
(1.10 and ILl) revealed a C ---7 G transversion at nucleotide position 
541 th at converts a leucine residue (CTC) to a valine (GTC) in one 
alle le (Langbein eta/, 1994). Tlus mutation , designated L159V, was 
not detected in an unaffected family member, II.2, by direct 
nucleotide sequencing. L159V was verified by the mismatch PCR 
method and ASO. Mismatch PCR was designed to create a Hin.cll 
recognition site only if codon 159 contains the mutant. As shown in 
Fig 2, the PCR products from 50 control individuals and unaffected 
fam ily members (1.2, 1.5, 1.8, and 11.2) did not possess the Hincii 
recognition site. Only the PCR products from the aftected family 
members (1.10 and II.l) demonstrated the presence of tlus muta-
tion . Assessment of the PCR products from control individuals and 
the unaftected family member (II.2) by ASO also failed to demon-
strate the presence of tlus mutation (Fig 2). 
DISCUSSION 
In tlus study we analyzed a family with EPPK and identified a novel 
mutation of a leucine residue to valine at codon 1.59 within the coil 
1 A segment of the rod domain of K9 . The coil 1A segment of the 
rod domain is highly conservative in the keratins, and all reported 
point mutations ofEPPK are within this domain (Bonifas eta/, 1994; 
Hennies eta/, 1994; Reis eta/, 1994; Torchard el al, 1994; Navsaria 
et al, 1995; Rothnagel eta/, 1995; Kobayas lu eta/, 1996). 1 , 2 The role 
of the coil 1 A segment for KJF assembly has been studied. Filament 
assembly and cross-linking studies proposed a structural model for 
molecular interactions in KJF (Hatzfeld and Weber, 1992; Steinert 
et a/, 1993a, 1993b; Compton, 1994) . According to this model, the 
first 10 or 11 residues of the coil lA segment of one molecule 
overlap with the last 10 or 11 residues of the coil 2B segment of the 
next mol ecule (Steinert, 1993) . On the other hand , a filament 
disassembly study reported that residue positions 7-16 of the coil 
1A segment are critical for the stability ofKJF (Steinert et al, 1993c). 
The leucine residue at codon159 ofK9 is the seventh residue of the 
coil 1A segment that is considered to be important for the assembly 
ofKJF anyway. In fact, the point mutation of tlus leuci11e residue to 
a phenylalanine residue of keratin 14 was reported in epidermolysis 
bu.llosa simplex (Y ammushi et a/, 1994). 
In our case, the L159V residue exchange appears undramatic, 
because leucine and valine are nonpolar residues and the substitu-
tion changes only the length of the hydrocarbon side chains. A 
point mutation of a nonpolar metluonine residue to a nonpolar 
valine residue at codon 156 of K9, however, was also reported in 
EPPK (Hemues et a/, 1994). In addition, it was reported that even 
more conservative substitutions could have profound deleterious 
effects on filament network formation and 10-nm filament assembly 
of vimentin . Substitution of glutamic acid for aspartic acid in the 
end of helix 2B of vimentin, wllich changed only the length of the 
hydrocarbons side chains, altered intermediate filament network 
formation i11 vitro (McCormick et al, 1993). Therefore, the L159V 
residue exchange will lead to the destabilization of filament net-
work formation and 1 0-nm filament assembly of K9. 
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